| Treatment Type | 5-Alpha Reductase Inhibitor |
| Availability | Prescription for men |
| Country Approval | Approved: United States, New Zealand, UK, Australia, Canada, European Community |
| Clinical Results | Moderate to dense regrowth in 48% of individuals after one year (compared to 7% placebo) and in 66% of individuals after two years (compared to 7% placebo). Overall hair count increase of 138 hairs per inch after two years compared to placebo. |
| Observed Results | Seem to match clinical results. May be improved with simultaneous use of Rogaine/Minoxidil 2% or 5% |
| Side Effects | In 2% or less of individuals decreased sexual desire, lowered sensitivy, or decreased ejaculate |
| Cost | $45-58 for a one month supply at pharmacies |
| Where You Can Get It Online | Hair2Go Other Pharmacy Sites |
- Higher Propecia Doses May Be Effective in Postmenopausal Women
- Propecia May Prevent Fibrosis
- Propecia in Topical Liposomes
- Regrowth Report: Propecia Phase III Clinical Study Results
- Propecia 2 Year Vertex Results
- Propecia 2 Year Frontal Results
- Sample photos of Propecia survey participants
- See Also: Proscar / Finasteride 5mg
- Merck Announcement of Propecia FDA Approval
- Regrowth Report: Two Year Results, Approval Predicted, Pricing Editorial
- Regrowth Report: Original Report Predicting Propecia and Rogaine Extra Strength Approval
- Regrowth Proscar Survey Results
- New Propecia Study: Biopsy Results of Men & Postmenopausal Women After One Year on Propecia
- Propecia Ineffective in Women
- Hair Loss News: University of Pennsylvania Study Confirms Frontal Effectiveness of Propecia
- Hair Loss Study Abstract:Propecia Does Not Affect Sperm Count or Spermatogenesis
- Hair Loss Study Abstract: Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia
- Hair Loss Study Abstract: The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial
- Hair Loss Study Abstract: Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
